|
Advancing ADT in HSPC: Interprofessional Intensification Strategies Reshaping Care |
04/24/2026 - 8:00am to 9:00am EDT |
|
Advancing ALK Inhibition into Early-Stage NSCLC—Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection |
09/19/2025 - 8:00am to 9:00am EDT |
|
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment |
01/30/2026 - 8:00am to 9:00am EST |
|
ALK+ NSCLC with Brain Metastasis |
04/16/2021 - 8:00am to 9:00am EDT |
|
All Oral Adjuvant Chemotherapy Regimen, CMC, for Early-Stage Breast Cancer: What’s Old is New |
12/02/2022 - 8:00am to 9:00am EST |
|
American Society of Hematology (ASH) 2020 Annual Meeting Highlights |
01/08/2021 - 8:00am to 9:00am EST |
|
American Society of Hematology (ASH) 2021 Annual Meeting Highlights |
01/07/2022 - 8:00am to 9:00am EST |
|
AML: An Overview Regarding Induction and Consolidation Options |
02/21/2025 - 8:00am to 9:00am EST |
|
Amyloidosis: Diagnosis and Treatment |
07/16/2021 - 8:00am to 9:00am EDT |
|
An Evolving Landscape: The Treatment for dMMR Colorectal Cancer |
04/17/2026 - 8:00am to 9:00am EDT |